object
purpos
case
report
describ
treatment
patient
acut
sinus
use
glycyrrhiza
glabra
clinic
featur
woman
present
acut
sinus
durat
symptom
includ
facial
pressur
sore
around
frontal
maxillari
sinus
headach
pharyng
fever
rhinorrhea
nasal
congest
postnas
drip
product
cough
myalgia
fatigu
intervent
outcom
administr
drop
tinctur
g
glabra
twice
day
improv
note
resolut
symptom
occur
day
treatment
conclus
treatment
acut
sinus
g
glabra
may
natur
therapeut
remedi
j
chiropr
med
acut
sinus
common
condit
seen
gener
practition
worldwid
estim
incid
sinus
million
peopl
year
unit
state
contribut
case
per
patient
episod
acut
sinus
preval
adult
second
lead
caus
infecti
diseas
encount
clinic
practic
women
greater
incid
infect
men
higher
probabl
seek
care
acut
sinus
infect
inflammatori
process
affect
nasal
passag
paranas
sinus
common
symptom
includ
facial
pain
rhinorrhea
pressur
full
sinus
nasal
obstruct
last
week
acut
sinus
diagnos
clinic
sign
symptom
importantli
presenc
purul
nasal
discharg
commonli
caus
viru
selflimit
condit
case
treat
symptomat
virus
transmit
induc
acut
sinus
associ
common
cold
virus
rhinoviru
influenza
viru
parainfluenza
viru
howev
case
acut
sinus
initi
viru
bacterium
haemophilu
influenza
convey
infect
well
bacterium
produc
toxin
interfer
ciliari
movement
damag
mucosa
stagnat
secret
caus
decreas
ciliari
movement
creat
perfect
cultur
medium
viral
bacteri
growth
peopl
higher
risk
contract
acut
sinus
includ
immunocompromis
work
close
peopl
convent
medicin
treatment
strategi
acut
sinus
emphas
use
antibiot
unit
state
sinus
patient
prescrib
antibiot
howev
evid
show
case
acut
sinus
viral
origin
margin
number
case
develop
secondari
bacteri
infect
pharmaceut
agent
employ
treatment
acut
sinus
oral
topic
decongest
topic
anticholinerg
antihistamin
mucolyt
nasal
corticosteroid
hyperton
salin
nasal
irrig
howev
research
relat
efficaci
form
therapi
acut
sinus
limit
studi
antibiot
combin
decongest
nasal
irrig
case
corticosteroid
prescrib
well
studi
shown
reduc
sever
symptom
studi
conduct
bahtoue
et
al
administ
nasal
decongest
antibiot
amoxicillinclavulan
acid
pseudoephedrin
intranas
salin
produc
addit
benefit
addit
studi
ragab
et
al
determin
nasal
irrig
effect
system
antibiot
day
treatment
howev
system
review
analyz
effect
salin
nasal
irrig
treatment
acut
sinus
author
conclud
evid
symptom
relief
studi
larg
enough
studi
group
high
risk
bia
case
acut
sinus
viral
natur
antibiot
use
prevent
secondari
infect
actual
efficaci
use
antibiot
primari
therapeut
approach
question
addit
small
number
studi
administ
anticholinerg
antihistamin
treatment
acut
sinus
studi
typic
use
allerg
rhiniti
rather
acut
viral
sinus
lastli
venekamp
et
al
perform
metaanalysi
found
oral
corticosteroid
monotherapi
ineffect
although
viral
acut
sinus
selflimit
without
treatment
complic
may
ensu
complic
occur
often
orbit
cellul
orbit
abscess
epidur
empyema
subdur
empyema
natur
altern
antibiot
treatment
either
bacteri
viral
sinus
glycyrrhiza
glabra
also
known
licoric
root
sweet
root
sweet
wort
grow
southwest
central
asia
europ
herb
perenni
reach
height
anchor
ground
taproot
reach
length
year
new
stem
grow
branch
give
rise
flower
leav
fruit
infloresc
plant
spike
like
appear
bluish
light
purpl
flower
g
glabra
one
differ
speci
plant
glycyrrhiza
genu
famili
leguminosa
first
document
use
g
glabra
medicin
purpos
date
back
ancient
assyria
egypt
around
bc
part
plant
use
medicin
root
stolon
tradit
g
glabra
use
reduc
inflamm
prevent
ulcer
act
mucolyt
block
calcium
channel
inhibit
microbi
growth
g
glabra
consid
gener
safe
howev
prolong
use
agent
recommend
result
hypertens
edema
cardiac
symptom
includ
cardiomyopathi
arrhythmia
pseudohyperaldosteron
conjunct
hypercortisol
polyuria
myopathi
lethargi
headach
tetani
retent
sodium
sever
disrupt
electrolyt
balanc
chronic
consumpt
result
hypertens
encephalopathi
case
excess
dosag
associ
hepatotox
metabol
alkalosi
reduct
testosteron
visual
disturb
g
glabra
contraind
individu
chronic
hepat
diabet
mellitu
sever
impair
renal
function
neuromuscular
disord
hyperton
cardiac
dysfunct
arrhythmia
hypertens
hypertonia
hypokalemia
g
glabra
herb
abil
act
antivir
hepat
b
c
influenza
herp
simplex
viru
sever
acut
respiratori
syndrom
coronaviru
respiratori
syncyti
viru
antivir
compon
g
glabra
glycyrrhizin
glycyrrhiz
acid
glycyrrhetin
acid
sever
antivir
action
g
glabra
establish
specif
viru
encount
shown
prevent
fusion
viru
membran
host
cell
increas
synthesi
interferon
lymphocyt
inhibit
enzymat
activ
virus
impair
replic
one
antivir
function
g
glabra
discuss
previous
potenti
product
interferon
lymphocyt
activ
mobil
immun
cell
combat
infect
anoth
effect
g
glabra
suppress
enzymat
activ
neuraminidas
neuraminidas
found
surfac
viru
facilit
cleavag
sialic
acid
residu
allow
activ
form
viru
detach
viral
infect
host
cell
separ
infect
host
cell
requir
viral
replic
transmiss
compon
g
glabra
inactiv
viral
neuraminidas
activ
sever
strain
influenza
includ
viru
oseltamivirresist
strain
studi
demonstr
antimicrobi
antivir
properti
g
glabra
howev
present
studi
demonstr
efficaci
g
glabra
treatment
acut
sinus
furthermor
studi
determin
effect
g
glabra
rhinoviru
parainfluenza
viru
h
influenza
bacterium
exist
studi
elucid
antivir
activ
g
glabra
influenza
vitro
use
g
glabra
part
formul
purpos
case
report
discuss
treatment
young
adult
femal
acut
sinus
administr
g
glabra
white
woman
present
facial
pressur
sore
around
frontal
maxillari
sinus
headach
pharyng
fever
rhinorrhea
nasal
congest
postnas
drip
product
cough
myalgia
fatigu
nocicept
sensat
induc
headach
experienc
predomin
frontal
maxillari
sinus
bilater
small
amount
clear
nasal
discharg
primari
symptom
experienc
sever
cough
fatigu
rhinorrhea
facial
tender
pressur
numer
scale
least
sever
sever
describ
cough
fatigu
rhinorrhea
facial
tender
pressur
respect
cumul
numer
score
overal
level
ill
experienc
symptom
day
perform
selfcar
first
day
infect
ad
clove
allium
sativum
breakfast
lunch
drop
tinctur
origanum
vulgar
oil
water
switch
tinctur
capsul
owe
difficulti
toler
tinctur
ingest
capsul
day
day
began
supplement
mg
zinc
emergenc
alcer
corpor
carlisl
pennsylvania
day
time
supplement
purchas
store
special
vitamin
supplement
profession
grade
also
receiv
acupunctur
twice
week
infect
experienc
mild
improv
sinu
pressur
nasal
congest
relief
transient
patient
fulltim
student
highli
activ
compet
amateur
fit
competit
perform
strength
train
exercis
day
per
week
endur
exercis
day
per
week
symptom
prevent
particip
daili
exercis
affect
progress
next
competit
past
medic
histori
sinus
occur
multipl
time
year
sinc
earli
childhood
usual
experienc
infect
everi
month
earlier
decemb
patient
present
urgent
care
treatment
upper
respiratori
tract
infect
sinus
prescrib
antituss
receiv
cortison
shot
also
selfprescrib
overthecount
decongest
expector
infect
last
day
succumb
anoth
infect
shortli
januari
overthecount
decongest
expector
allevi
symptom
day
upon
examin
throat
mildli
erythemat
thin
layer
clear
mucou
nasal
mucosa
red
inflam
clear
mucou
nasal
passag
percuss
frontal
maxillari
sinus
reveal
tender
pain
sinus
transillumin
consist
inflamm
mucosa
obstruct
owe
mucu
base
upon
histori
physic
examin
diagnos
case
acut
sinus
tinctur
g
glabra
treatment
prescrib
patient
dosag
drop
tinctur
twice
day
day
dosag
g
glabra
tinctur
mg
drop
patient
subject
report
feel
better
first
day
treatment
g
glabra
symptom
score
reduc
cough
fatigu
rhinorrhea
facial
tender
pressur
respect
overal
rate
ill
second
day
treatment
subject
report
felt
better
rhinorrhea
nasal
congest
fever
myalgia
pharyng
resolv
symptom
score
reduc
cough
fatigu
facial
pressur
tender
respect
overal
rate
level
ill
tabl
day
resolut
symptom
occur
howev
prevent
remiss
continu
ingest
tinctur
g
glabra
twice
day
day
followup
perform
octob
begin
octob
experienc
dri
cough
fatigu
rhinorrhea
first
day
notic
symptom
administ
drop
tinctur
g
glabra
describ
symptom
day
respect
numer
scale
cough
fatigu
rhinorrhea
respect
symptom
intensifi
cough
fatigu
rhinorrhea
respect
day
day
subsequ
symptom
reduc
allevi
end
day
tabl
patient
instruct
clinic
present
determin
exact
extent
posit
effect
g
glabra
patient
howev
would
appear
g
glabra
may
attenu
symptom
day
administr
receiv
acupunctur
twice
week
administ
g
glabra
supplement
zinc
emergenc
sativum
vulgar
oil
day
treatment
strategi
may
therapeut
effect
discount
acupunctur
zinc
sativum
vulgar
potenti
enhanc
immun
function
addit
zinc
sativum
vulgar
possess
antioxid
agent
activ
ingredi
emergenc
may
mild
immuneenhanc
effect
great
antioxid
potenti
sativum
vulgar
also
antimicrobi
howev
research
exist
demonstr
sativum
antivir
antivir
effect
vulgar
research
larg
unknown
consequ
combin
immunostimulatori
antioxid
function
zinc
emergenc
vulgar
sativum
conjunct
antivir
activ
sativum
reduc
sever
ill
symptom
howev
effect
margin
probabl
explan
minim
improv
herb
supplement
use
long
enough
period
time
may
administ
frequent
enough
use
consist
basi
case
although
g
glabra
may
effect
resolv
acut
sinus
caus
factor
infect
known
pathogen
respons
ill
may
viru
preval
bacterium
unfortun
inform
demonstr
effect
g
glabra
treatment
acut
sinus
regardless
sourc
addit
evid
pertain
effect
g
glabra
pathogen
caus
acut
sinus
limit
virus
affili
onset
acut
sinus
one
vitro
studi
perform
grienk
et
al
reveal
sever
compon
g
glabra
inhibit
neuraminidas
activ
could
prevent
replic
influenza
data
show
g
glabra
effect
antibacteri
agent
howev
inform
avail
activ
inact
h
influenza
bacterium
associ
sinus
nevertheless
g
glabra
may
respons
erad
infect
consider
patient
typic
would
experi
episod
acut
sinus
everi
month
case
use
g
glabra
week
succumb
infect
month
later
slight
improv
howev
upon
administr
g
glabra
experienc
lowgrad
infect
resolv
day
afflict
anoth
infecti
agent
novemb
januari
may
indic
g
glabra
administ
appropri
prevent
sever
infect
ensu
howev
imposs
determin
becuas
caus
infect
unknown
may
come
contact
less
virul
strain
analog
viru
differ
less
sever
strain
viru
first
infect
although
contagion
respons
diseas
known
antivir
antibacteri
data
minim
g
glabra
possess
properti
make
appropri
treatment
acut
sinus
main
effect
herb
shown
research
inhibit
dehydrogenas
reductas
liver
metabol
cortisol
cortison
cortison
inact
form
downregul
activ
enzym
increas
circul
level
cortisol
addit
evid
demonstr
glycyrrhiz
acid
glycyrrhetin
acid
interact
glucocorticoid
receptor
may
regulatori
effect
howev
regulatori
effect
weak
studi
exemplifi
potenti
modulatori
effect
g
glabra
first
studi
perform
methli
et
al
use
g
glabra
patient
addison
diseas
g
glabra
increas
serum
cortisol
level
hour
consumpt
wherea
studi
conduct
armanini
et
al
glycyrrhetin
acid
administ
topic
onto
thigh
healthi
women
applic
glycyrrhetin
acid
decreas
activ
cortisol
adipocyt
demonstr
abil
g
glabra
potenti
regul
cortisol
activ
rais
cortisol
level
seem
counterintuit
treatment
infect
immunosuppress
prooxid
effect
cortisol
act
immunosuppress
agent
acceler
cellular
metabol
increas
oxid
stressgener
reactiv
oxygen
speci
ro
greater
level
ro
produc
stress
place
bodi
secret
cortisol
compens
higher
amount
cortisol
releas
compound
immunosuppress
effect
level
oxid
stress
exacerb
immun
respons
form
phagocyt
facilit
respiratori
burst
infect
respiratori
burst
use
ro
erad
pathogen
combin
glucocorticoid
releas
respiratori
burst
promot
synthesi
ro
increas
level
oxid
stress
impair
antioxid
defens
system
use
antioxid
supplement
shown
prevent
dysfunct
antioxid
defens
system
diminish
ro
reduc
serum
cortisol
mitig
immunosuppress
effect
howev
effect
g
glabra
cortisol
consid
analog
administr
oral
corticosteroid
treatment
acut
sinus
lesser
extent
practic
prescrib
oral
corticosteroid
certain
infect
becom
preval
reason
inflamm
occur
parallel
infect
administ
cortisol
agonist
dissip
inflammatori
respons
allevi
symptom
least
temporarili
although
cortisol
immunosuppress
effect
downregul
inflamm
could
lower
cortisol
level
longterm
higher
level
inflamm
posit
correl
higher
level
cortisol
releas
consequ
effect
g
glabra
may
attenu
releas
cortisol
time
similar
mechan
g
glabra
reduc
inflamm
action
besid
elev
cortisol
glycyrrhiz
acid
potenti
antiinflammatori
activ
g
glabra
downregul
express
nuclear
transcript
factor
associ
inflamm
anoth
compon
known
glabridin
act
directli
cyclooxygenas
inhibit
synthesi
inflammatori
prostaglandin
thromboxan
associ
inflamm
g
glabra
abil
reduc
inflammatori
mediat
induc
nitric
oxid
synthas
tumor
necrosi
interleukin
interleukin
effect
could
reduc
inflamm
suppress
cortisol
secret
concurr
agent
antioxid
properti
reduc
cortisol
secret
g
glabra
possess
activ
constitu
antioxid
properti
capac
lower
ro
sever
mechan
explain
potent
reduct
ro
one
studi
hejazi
et
al
demonstr
g
glabra
enhanc
ro
scaveng
effect
superoxid
dismutas
catalas
glutathion
peroxidas
glutathion
stransferas
addit
g
glabra
reduc
nitrogen
radic
enhanc
mitochondri
function
cellular
metabol
abat
initi
product
free
radic
abil
lower
ro
g
glabra
decreas
total
level
oxid
stress
indirectli
imped
cortisol
releas
therefor
although
g
glabra
shown
increas
releas
cortisol
immunosuppress
weak
cortisol
modulatori
activ
antiinflammatori
antioxid
potenti
g
glabra
may
hinder
cortisol
releas
lessen
immunosuppress
effect
cortisol
howev
g
glabra
may
attenu
immunosuppress
activ
cortisol
anoth
mechan
g
glabra
stimulatori
effect
immun
system
g
glabra
increas
product
tlymphocyt
especi
cell
also
potenti
activ
tlymphocyt
natur
killer
cell
g
glabra
increas
express
ligand
express
cell
ligand
promot
differenti
b
cell
activ
monocyt
macrophag
enhanc
immun
respons
ligand
immunoglobulin
involv
activ
cell
addit
g
glabra
increas
transcript
major
histocompat
complex
mhc
ii
major
histocompat
complex
ii
synthes
dendrit
cell
macrophag
b
cell
cell
phagocyt
capabl
engulf
pathogen
metabol
attach
mhc
ii
phagocyt
cell
travel
lymphoid
tissu
present
antigen
attach
mhc
ii
cell
stimul
immun
respons
combin
immuneenhanc
potenti
immunosuppress
effect
cortisol
releas
caus
g
glabra
classifi
immunomodulatori
agent
consequ
exact
extent
activ
g
glabra
posit
effect
toward
allevi
infect
difficult
distinguish
howev
augment
antiinflammatori
antioxid
activ
bodi
possess
immunostimulatori
properti
theori
could
negat
neg
immunosuppress
effect
cortisol
addit
g
glabra
use
expector
antituss
agent
expector
g
glabra
may
enhanc
excret
mucu
pulmonari
system
limit
inform
expector
effect
g
glabra
mechan
poorli
understood
antituss
agent
may
reduc
sever
cough
g
glabra
shown
act
calcium
channel
blocker
smooth
muscl
respiratori
tract
antituss
effect
demonstr
studi
agarw
et
al
studi
tinctur
g
glabra
administ
patient
surgeri
surgeri
found
individu
prescrib
tinctur
g
glabra
less
pronounc
cough
anoth
studi
liu
et
al
found
isoliquiritigenin
compon
g
glabra
abil
act
spasmolyt
trachea
guinea
pig
exact
caus
acut
sinus
known
patient
without
know
exact
caus
difficult
determin
reason
sativum
vulgar
produc
minim
therapeut
effect
g
glabra
potenti
elimin
infect
patient
infect
day
selfprescrib
antioxid
immun
stimul
supplement
receiv
acupunctur
possibl
know
effect
therapeut
modal
immun
function
possibl
allevi
infect
may
posit
effect
immun
system
allow
resolut
symptom
administr
g
glabra
may
pure
coincident
howev
seem
unlik
patient
inconsist
took
supplement
first
day
infect
receiv
acupunctur
twice
supplement
day
receiv
acupunctur
day
receiv
g
glabra
anoth
limit
factor
resolut
sign
symptom
subject
base
numer
scale
instrument
use
true
improv
observ
estim
exact
valu
addit
object
outcom
measur
would
increas
understand
effect
g
glabra
lastli
previou
case
acut
sinus
typic
resolv
around
week
administr
g
glabra
day
infect
immun
system
may
overcom
infect
anyway
howev
symptom
improv
quickli
administr
g
glabra
usual
seen
pattern
sinus
also
fact
reoccur
infect
everi
month
anoth
infect
month
later
may
indic
improv
immun
function
addit
infect
occur
octob
low
grade
succumb
anoth
infect
novemb
januari
may
indic
g
glabra
effect
allevi
second
infect
research
requir
determin
effici
g
glabra
treatment
acut
sinus
viral
infect
day
infect
acut
sinus
receiv
therapi
intermitt
experienc
minim
improv
g
glabra
may
help
allevi
symptom
patient
within
day
hypothes
g
glabra
may
resolv
symptom
reduc
inflamm
act
antioxid
act
cortisol
regul
interact
cortisol
receptor
g
glabra
act
immunostimul
expector
antituss
agent
also
may
help
resolv
patient
symptom
g
glabra
may
effect
therapeut
agent
treatment
acut
case
viral
bacteri
sinus
either
alon
combin
antivir
mucolyt
agent
fund
sourc
conflict
interest
report
studi
